---
title: "Klotho Neurosciences, Inc. (KLTO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/KLTO.US.md"
symbol: "KLTO.US"
name: "Klotho Neurosciences, Inc."
industry: "Biotechnology"
---

# Klotho Neurosciences, Inc. (KLTO.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [klothoneuro.com](https://klothoneuro.com) |

## Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer’s disease; and KLTO-202, a gene therapy product for treatment and prev...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.46 | 319/606 | - | - | - |
| PB | 3.94 | 268/606 | 10.43 | 3.88 | 2.77 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/KLTO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/KLTO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/KLTO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.